Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder

Experimental and Clinical Transplantation

Volumn 7, Issue 1, 2009, Pages 58-61

  Azarpira, Negar ^a   Torabineghad, Simin ^b   Rakei, Mohamad ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

B cell; Epstein Barr virus; Immunosuppressive therapy; Renal transplant; Viral load monitoring

Indexed keywords

CD20 ANTIGEN; CREATINE; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BRAIN SURGERY; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIPLOPIA; DYSPHAGIA; EPSTEIN BARR VIRUS; HEADACHE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CRANIOTOMY; OCCIPITAL LOBE; PARIETAL LOBE; PATHOLOGY; SKULL IRRADIATION; TREATMENT OUTCOME; VIROLOGY; VIRUS INFECTION;

BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CRANIAL IRRADIATION; CRANIOTOMY; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MAGNETIC RESONANCE IMAGING; MALE; OCCIPITAL LOBE; PARIETAL LOBE; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649231536     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Lim WH, Russ GR, Coates PT. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Nephrology (Carlton). 2006;11(4):355-366.
2. Pourfarziani V, Taheri S, Lessan-Pezeshki M, et al. Lymphoma after living donor kidney transplantation: an Iranian multicenter experience. Int Urol Nephrol. 2008;40(4):1089-1094.
3. Collins MH, Montone KT, Leahey AM, et al. Post-transplant lymphoproliferative disease in children. Pediatr Transplant. 2001;5(4):250-257.
4. Opelz G, Döhler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant. 2003;4(2):222-230.
5. Newell KA, Alonso EM, Whitington PF, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation. 1996;62(3):370-375.
6. Caillard S, Dharnidharka V, Agodoa L, et al. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005;80(9):1233-1243.
7. Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders: Summary of Society for Hematopathology Workshop. Semin Diagn Pathol. 1997;14(1):8-14.
8. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November, 1997. Hematol J. 2000;1(1):53-66.
9. Hoshida Y, Li T, Dong Z, et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int J Cancer. 2001;91(6):869-875.
10. Higuchi M, Hata T, Furuya S, et al. Epstein-Barr virus-related primary central nervous system lymphoma after cadaveric renal transplantation improved by treatment with high-dose methotrexate followed by irradiation. Nephrology (Carlton). 2005;10(3):321-324.
11. Snanoudj R, Durrbach A, Leblond V, et al. Primary brain lymphomas after kidney transplantation: presentation and outcome. Transplantation. 2003;76(6):930-937.
12. O'Neill BP, Vernino S, Dogan A, et al. EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neuro Oncol. 2007;9(3):364-369.